BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

Senti Biosciences Holdings Inc. – Material Contracts

NASDAQ: SNTI    
Share price (8/7/26): $0.35    
Market cap (8/7/26): $11.0 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from DEFA14A 18 pages Contingent Value Rights Agreement
12/34/56
EX-10.1
from 8-K 18 pages Contingent Value Rights Agreement
12/34/56
EX-10.1
from 8-K 54 pages Senti Holdings, Inc. Senior Secured Convertible Note
12/34/56
EX-10.4
from 10-Q 3 pages September 1, 2025 Senti Biosciences, Inc. Two Corporate Drive South San Francisco, Ca 94080 Attention: Rob Cutler Re: Sublease Amendment and Genefab Work Dear Rob
12/34/56
EX-10.3
from 10-Q 6 pages First Amendment to Landlord’s Consent to Sublease
12/34/56
EX-10.2
from 10-Q 7 pages First Amendment to Sublease Agreement
12/34/56
EX-10.1
from 10-Q 10 pages First Amendment to Lease
12/34/56
EX-10.5
from 8-K 8 pages Voting Agreement
12/34/56
EX-10.4
from 8-K 18 pages Registration Rights Agreement
12/34/56
EX-10.3
from 8-K 9 pages Guarantee (This “Guarantee”), Dated as of [__], 2026, Made by Each of the Undersigned (Each a “Guarantor”, and Collectively, the “Guarantors”), in Favor of the Secured Parties (As Defined Below) in Connection With the Securities Purchase Agreement, the Notes and Each Other Transaction Document Referenced Below
12/34/56
EX-10.2
from 8-K 48 pages Senti Holdings, Inc. Senior Secured Convertible Note
12/34/56
EX-10.1
from 8-K 39 pages Securities Purchase Agreement
12/34/56
EX-10.7
from 8-K12B 11 pages Senti Biosciences Holdings, Inc. Amended and Restated 2022 Employee Stock Purchase Plan Adopted by the Board of Directors: April 24, 2026 Approved by the Stockholders: April 24, 2026
12/34/56
EX-10.6
from 8-K12B 36 pages Senti Biosciences Holdings, Inc. Amended and Restated 2022 Inducement Plan Adopted by the Board of Directors: April 24, 2026
12/34/56
EX-10.5
from 8-K12B 38 pages Senti Biosciences Holdings, Inc. Amended and Restated 2022 Equity Incentive Plan
12/34/56
EX-10.4
from 8-K12B 21 pages Senti Biosciences Holdings, Inc. Amended and Restated 2016 Stock Incentive Plan Adopted by the Board of Directors: April 24, 2026 Approved by the Stockholders: April 24, 2026
12/34/56
EX-10.3
from 8-K12B 4 pages Assignment and Assumption Agreement
12/34/56
EX-10.2
from 8-K12B 7 pages Amended and Restated Designation Agreement April 24, 2026
12/34/56
EX-10.1
from 8-K12B 7 pages Amended and Restated Designation Agreement April 24, 2026
12/34/56
EX-10.1
from 10-Q 2 pages Amended and Restated Sow #2 Under Consulting Agreement Original Effective Date: February 4, 2025
12/34/56